AU2002304281A1 - Novel form of n-(trans-4-isopropylcyclohexylcarbonyl)-d-phenylalanine - Google Patents

Novel form of n-(trans-4-isopropylcyclohexylcarbonyl)-d-phenylalanine Download PDF

Info

Publication number
AU2002304281A1
AU2002304281A1 AU2002304281A AU2002304281A AU2002304281A1 AU 2002304281 A1 AU2002304281 A1 AU 2002304281A1 AU 2002304281 A AU2002304281 A AU 2002304281A AU 2002304281 A AU2002304281 A AU 2002304281A AU 2002304281 A1 AU2002304281 A1 AU 2002304281A1
Authority
AU
Australia
Prior art keywords
trans
isopropylcyclohexylcarbonyl
phenylalanine
methyl ester
phenylalanine methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002304281A
Other languages
English (en)
Inventor
Chandrashekar Aswathanarayanappa
Sambasivam Ganesh
Tom T Puthiaparampil
Shanmughasamy Rajamahendra
Madhavan Sridharan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biocon Ltd
Original Assignee
Biocon Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocon Ltd filed Critical Biocon Ltd
Publication of AU2002304281A1 publication Critical patent/AU2002304281A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C233/63—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2002304281A 2002-04-29 2002-04-29 Novel form of n-(trans-4-isopropylcyclohexylcarbonyl)-d-phenylalanine Abandoned AU2002304281A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN2002/000114 WO2003093222A1 (en) 2002-04-29 2002-04-29 Novel form of n-(trans-4-isopropylcyclohexylcarbonyl)-d-phenylalanine

Publications (1)

Publication Number Publication Date
AU2002304281A1 true AU2002304281A1 (en) 2003-11-17

Family

ID=29287383

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002304281A Abandoned AU2002304281A1 (en) 2002-04-29 2002-04-29 Novel form of n-(trans-4-isopropylcyclohexylcarbonyl)-d-phenylalanine

Country Status (13)

Country Link
US (1) US7314955B2 (enExample)
EP (1) EP1499586A4 (enExample)
JP (1) JP4137053B2 (enExample)
KR (1) KR20040111490A (enExample)
AU (1) AU2002304281A1 (enExample)
CA (1) CA2481322A1 (enExample)
CZ (1) CZ2004997A3 (enExample)
HR (1) HRP20040920A2 (enExample)
HU (1) HUP0500259A2 (enExample)
IL (1) IL164327A0 (enExample)
MX (1) MXNL04000084A (enExample)
SK (1) SK287644B6 (enExample)
WO (1) WO2003093222A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ2004997A3 (cs) 2002-04-29 2005-01-12 Biocon Limited Nová forma N-(trans-4-isopropylcyklohexylkarbonyl)-D-fenylalaninu
US6861553B2 (en) 2002-07-03 2005-03-01 Teva Pharmaceuticals Industries Ltd. Process for preparing nateglinide and intermediates thereof
US7148376B2 (en) 2002-07-18 2006-12-12 Teva Pharmaceutical Industries Ltd. Polymorphic forms of nateglinide
US7358390B2 (en) 2002-07-18 2008-04-15 Teva Pharmaceutical Industries Ltd. Polymorphic forms of nateglinide
US7420084B2 (en) 2002-07-18 2008-09-02 Teva Pharmaceutical Industries Ltd. Polymorphic forms of nateglinide
US7534913B2 (en) 2002-07-18 2009-05-19 Teva Pharmaceutica Industries Ltd. Crystalline form of nateglinide
WO2004020396A1 (en) * 2002-08-28 2004-03-11 Dr. Reddy's Laboratories Limited Crystalline form of nateglinide and process for preparation thereof
WO2004074330A1 (ja) * 2003-02-18 2004-09-02 Konishi Co., Ltd. 硬化性樹脂、その製造方法及び硬化性樹脂組成物
HU227073B1 (hu) * 2003-07-10 2010-06-28 Richter Gedeon Nyrt Eljárás királisan tiszta N-(transz-4-izopropil-ciklohexilkarbonil)-D-fenil-alanin (nateglinid) és kristálymódosulatainak elõállítására, valamint a G-kristálymódosulata
US20070231393A1 (en) * 2004-05-19 2007-10-04 University Of South Carolina System and Device for Magnetic Drug Targeting with Magnetic Drug Carrier Particles
GB0413084D0 (en) * 2004-06-11 2004-07-14 Cipla Ltd Process
US20100004334A1 (en) * 2008-07-01 2010-01-07 Mead Johnson Nutrition Company Nutritional Compositions Containing Punicalagins
US11390830B2 (en) 2018-10-05 2022-07-19 The Chemours Company Fc, Llc Compositions comprising 1,2-dichloro-1,2-difluoroethylene for use in cleaning and solvent applications

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6354321A (ja) * 1985-03-27 1988-03-08 Ajinomoto Co Inc 血糖降下剤
US4814684A (en) * 1987-09-30 1989-03-21 Trw Inc. Apparatus for extending the Vout/Vin ratio of a DC-to-DC converter
EP0526171B1 (en) * 1991-07-30 1997-03-05 Ajinomoto Co., Inc. Crystals of N-(trans-4-isopropylcyclohexylcarbonyl)-D-phenylalanine and methods for preparing them
US5463116A (en) * 1991-07-30 1995-10-31 Ajinomoto Co., Inc. Crystals of N- (trans-4-isopropylcyclohexlycarbonyl)-D-phenylalanine and methods for preparing them
CZ2004997A3 (cs) 2002-04-29 2005-01-12 Biocon Limited Nová forma N-(trans-4-isopropylcyklohexylkarbonyl)-D-fenylalaninu

Also Published As

Publication number Publication date
SK50052004A3 (sk) 2005-03-04
WO2003093222A1 (en) 2003-11-13
EP1499586A1 (en) 2005-01-26
KR20040111490A (ko) 2004-12-31
US20050165108A1 (en) 2005-07-28
HUP0500259A2 (hu) 2005-06-28
IL164327A0 (en) 2005-12-18
MXNL04000084A (es) 2006-02-28
EP1499586A4 (en) 2006-01-18
JP2005523933A (ja) 2005-08-11
JP4137053B2 (ja) 2008-08-20
HRP20040920A2 (en) 2005-02-28
SK287644B6 (sk) 2011-05-06
CZ2004997A3 (cs) 2005-01-12
CA2481322A1 (en) 2003-11-13
US7314955B2 (en) 2008-01-01

Similar Documents

Publication Publication Date Title
US7314955B2 (en) Form of N-(trans-4-isopropylcyclohexylcarbonyl)-D-phenylalanine
TWI716458B (zh) γ-羥基丁酸的前藥及其組合物和用途
WO1997049681A1 (en) Polymorphic compounds
EP1098870A2 (en) Nitric esters and nitrate salts of specific drugs
WO2009132593A1 (zh) 喹啉类化合物及其药物组合物、制备方法和应用
CN1041933C (zh) 克拉维酸的二胺盐及其制备方法和用途
JPS6253966A (ja) 新規ピリジン誘導体
CN102317256A (zh) 制备消旋卡多曲的方法
JPH02306947A (ja) キラルβ―アミノ酸の製造方法
WO2014057495A1 (en) A process for industrial preparation of [(s)-n-tert butoxycarbonyl-3-hydroxy]adamantylglycine
CN103232398B (zh) 一种瑞舒伐他汀氨基酸盐及其制备方法和应用
KR100224330B1 (ko) 골관절 질환의 치료에 유용한 n-((4,5-디히드록시-및 4,5,8-트리히드록시-9,10-디히드로-9,10-디옥소-2-안트라센-일)카르보닐)아미노산
CN106008384B (zh) 一种缬沙坦的精制方法
RU2324676C2 (ru) Кристаллический n-(транс-4-изопропилциклогексилкарбонил)-d-фенилаланин формы с для лечения сахарного диабета типа 2 и способ его получения
JP5745050B2 (ja) 新規モンテルカスト４−ハロベンジルアミン塩およびこれを用いたモンテルカストナトリウム塩の製造方法
WO2023143158A1 (zh) 苯酚衍生物、及其晶型与制备方法
JP7457033B2 (ja) アルドース還元酵素阻害剤の塩、及びその製造方法と使用
CN105859611A (zh) 一种阿扎那韦硫酸氢盐a型结晶的制备方法
CN106565822A (zh) 手性l‑丙氨酰‑苯丙氨酸的制备方法
WO2021109883A1 (zh) 用于制备奥贝胆酸的方法
EP1709001A2 (en) Solid forms of montelukast acid
JP2002540101A (ja) プロピオン酸３−アミノ−３−アリールの合成
US20070135513A1 (en) Method for producing {n-[1-(s)-carbalkoxy-3-phenylpropyl]-s-alanyl-2s, 3ar, 7as-octahydroindole-2-carboxylic acid} compounds
CN1085655C (zh) 光学纯联萘二酚单基碳酸酯的制备方法
WO2024093678A1 (zh) 含有多环结构的γ-氨基丁酸衍生物及其制备方法和用途

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application